|
|
Thefeasibility analysisofWenyanghuoxuePrescription ofChinese medicine auxiliarily treating chronic heart failure |
HUANG Zhang-yu1 ZENG Guo-han2 |
1.Department of Internal Medicine,Xuwen Maternal and Child Health Hospital of Xuwen County in Zhanjiang City,Guangdong Province,Xuwen 524100,China;2.Department of Emergency,Xuwen Maternal and Child Health Hospital of Xuwen County in Zhanjiang City,Guangdong Province,Xuwen 524100,China |
|
|
Abstract ObjectiveTo observe the clinical effect of Wenyanghuoxue Prescription of Chinese medicine auxiliarily treating chronic heart failure,and to explore its rationality and applicability.MethodsFifty patients with heart failure patients treated in our hospital from February 2015 and December 2017 were selected and the patients were divided into the control group(n=25)and treatment group(n=25).The control group was treated with traditional western medicine,and the treatment group was treated with self-made Wenyanghuoxue Prescription based on the control group.The treatment effect of the two groups was observed.ResultsThe total effective rate of the treatment group was significantly higher than that of the control group (P<0.05).The value of left ventricular ejection fraction (LEVF)in the two groups was higher than that before treatment(P<0.05),and the value of LEVF in the treatment group was higher than that of the control group,the difference was statistically significant(P<0.01).The level of brain natriuretic peptide (BNP)after treatment in the two groups was lower than that before treatment(P<0.05),and the level of BNP in the treatment group was lower than that of the control group (P<0.01).ConclusionThe effect of Wenyanghuoxue Prescription of Chinese medicine auxiliarily treating chronic heart failure is good,and it can obviously improve the LEVF,BNP of patients.For the patients with heart failure,the treatment of Wenyangyiqi based on western medicine is more obvious and worth promoting.
|
|
|
|
|
[1] |
顾广富,杨冬花,罗建华.益气温阳活血方对慢性心力衰竭大鼠心室重塑相关因子的影响[J].贵州医药,2015,39(4):292-294.
|
[2] |
杨冬花,顾广富,罗建华.益气温阳活血方对慢性心力衰竭心室重塑大鼠β3-肾上腺素能受体、血清Ⅰ型前胶原羧基端肽和Ⅲ型前胶原氨基端肽的影响[J].中国老年学杂志,2016,36(19):4678-4680.
|
[3] |
武俊华,梁菲菲,赵晓秋.温阳活血方加减对慢性充血性心力衰竭患者内皮素及脑利钠肽影响研究[J].山西医药杂志,2016,45(3):305-307.
|
[4] |
贾宏育.益气温阳活血利水中药治疗冠心病心力衰竭的临床效果观察[J].中国现代药物应用,2017,11(7):190-191.
|
[5] |
梁益辉,王国珍,王棱杏等.益气温阳活血利水中药治疗冠心病心力衰竭的临床疗效[J].内蒙古中医药,2017,36(10):2-3.
|
[6] |
耿冲,安冬青,谢冲等.益气温阳、活血利水法联合西药与常规西药治疗慢性心力衰竭临床疗效比较的Meta分析[J].中国全科医学,2015,18(2):180-183,190.
|
[7] |
刘国安.温阳活血方辅治心力衰竭的效果观察[J].临床合理用药杂志,2017,10(17):24-25.
|
[8] |
杜生华.益气温阳活血汤治疗心力衰竭随机平行对照研究[J].实用中医内科杂志,2016,30(8):60-62.
|
[9] |
张良,刘新文,王雅珍等.益气温阳活血利水法联合西药治疗慢性心力衰竭的疗效及对循环miRNAs表达的影响[J].中国药师,2017,20(12):2183-2186.
|
[10] |
林能波,江晓波,郑炜华.温阳活血法联合常规西药治疗冠心病心力衰竭的临床价值研究[J].齐齐哈尔医学院学报,2016,37(32):4014-4015.
|
[11] |
王健,刘丽.温阳活血方对慢性心衰大鼠心肌组织转化生长因子 β1的影响[J].实用中医药杂志,2017,33(2):110-112.
|
[12] |
赖吉珍.益气温阳、活血利水法治疗慢性充血性心力衰竭的研究进展[J].山东中医杂志,2017,36(6):533-536.
|
[13] |
周爱淇.温阳活血化痰法治疗老年心力衰竭的临床研究[D].合肥:安徽中医药大学,2015.
|
[14] |
王健,姚灿坤.温阳活血方对慢性心力衰竭大鼠心肌纤维化的影响[J].湖南中医杂志,2017,33(5):155-157.
|
[15] |
仇卫锋,刘佳,向宗兴.温阳活血方联合西药治疗慢性心力衰竭 55 例[J].陕西中医,2016,37(2):185-187.
|
|
|
|